Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$247M |
| 2 |
Johnson & Johnson
JNJ
|
+$225M |
| 3 |
MON
Monsanto Co
MON
|
+$213M |
| 4 |
AET
Aetna Inc
AET
|
+$208M |
| 5 |
Broadcom
AVGO
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$227M |
| 2 |
Microsoft
MSFT
|
+$224M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$205M |
| 4 |
Nike
NKE
|
+$187M |
| 5 |
Pfizer
PFE
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.75% |
| 2 | Technology | 13.74% |
| 3 | Healthcare | 12.69% |
| 4 | Industrials | 11.51% |
| 5 | Consumer Discretionary | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMH
1826
DELISTED
Impac Mortgage Holdings Inc.
IMH
| $3.95M | 0.01% |
281,600
+239,600
| +570% | +$3.54M |
|
1827
Interface
TILE
$2.19B
| $3.93M | 0.01% |
212,100
-48,200
| -19% | -$831K |
|
|
DCT
1828
DELISTED
DCT Industrial Trust Inc.
DCT
| $3.93M | 0.01% |
+82,100
| New | +$3.78M |
|
1829
Unum
UNM
$14.8B
| $3.93M | 0.01% |
+89,400
| New | +$3.58M |
|
1830
Rexford Industrial Realty
REXR
$8.08B
| $3.92M | 0.01% |
168,900
+124,000
| +276% | +$2.72M |
|
|
ACHN
1831
DELISTED
Achillion Pharmaceuticals
ACHN
| $3.9M | 0.01% |
945,189
+392,589
| +71% | +$2.09M |
|
|
GIFI
1832
DELISTED
Gulf Island Fabrication
GIFI
| $3.89M | 0.01% |
326,929
+94,649
| +41% | +$1.03M |
|
|
FENG
1833
Phoenix New Media
FENG
$18.1M
| $3.89M | 0.01% |
206,367
-383
| -0.2% | -$8.46K |
|
|
ABCD
1834
DELISTED
Cambium Learning Group, Inc.
ABCD
| $3.87M | 0.01% |
776,100
+3,900
| +0.5% | +$19.6K |
|
1835
SS&C Technologies
SSNC
$19.1B
| $3.87M | 0.01% |
+135,300
| New | +$4.19M |
|
1836
Box
BOX
$4.52B
| $3.86M | 0.01% |
278,800
+60,500
| +28% | +$895K |
|
|
GCAP
1837
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $3.86M | 0.01% |
587,200
+9,600
| +2% | +$57.8K |
|
|
MODN
1838
DELISTED
MODEL N, INC.
MODN
| $3.86M | 0.01% |
435,900
-171,100
| -28% | -$1.59M |
|
1839
Vicor
VICR
$10.8B
| $3.85M | 0.01% |
255,200
-9,000
| -3% | -$124K |
|
1840
Resources Connection
RGP
$145M
| $3.83M | 0.01% |
199,200
-74,500
| -27% | -$1.19M |
|
|
MRLN
1841
DELISTED
Marlin Business Services Corp
MRLN
| $3.82M | 0.01% |
182,900
+39,100
| +27% | +$776K |
|
|
XCO
1842
DELISTED
Exco Resources
XCO
| $3.82M | 0.01% |
291,467
+53,840
| +23% | +$865K |
|
1843
Petrobras Class A
PBR.A
$104B
| $3.82M | 0.01% |
+433,524
| New | +$4.13M |
|
|
KEYW
1844
DELISTED
The KEYW Holding Corporation
KEYW
| $3.82M | 0.01% |
323,900
+296,400
| +1,078% | +$3.49M |
|
|
BFYT
1845
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $3.82M | 0.01% |
213,900
+195,000
| +1,032% | +$1.9M |
|
|
ITCL
1846
DELISTED
Banco Itau Chile American Depositary Shares (each representing one third of one (1/3) Common Share)
ITCL
| $3.81M | 0.01% |
306,466
+27,720
| +10% | +$353K |
|
1847
Civista Bancshares
CIVB
$593M
| $3.81M | 0.01% |
196,000
+77,700
| +66% | +$1.27M |
|
1848
OFG Bancorp
OFG
$2.28B
| $3.8M | 0.01% |
+289,953
| New | +$3.48M |
|
1849
Crawford & Co Class A
CRD.A
$632M
| $3.79M | 0.01% |
400,500
+72,400
| +22% | +$693K |
|
|
MR
1850
DELISTED
Montage Resources Corporation Common Stock
MR
| $3.78M | 0.01% |
94,360
+3,933
| +4% | +$175K |
|
Similar funds
Jim Simons's Q4 2016 Portfolio in Review
As of Q4 2016, Jim Simons held 3,715 positions worth $63.2B, up 12% from $56.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Jim Simons deployed $5.07B of net new capital in Q4 2016, opening 418 new positions and adding to 1,792 existing holdings. Its largest new stake was Broadcom: 10,144,960 shares worth $179M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $227M trimmed.
- Jim Simons's largest Q4 2016 buy was Broadcom: 10,144,960 shares worth $179M.
- Jim Simons added most to Gilead Sciences in Q4 2016, an estimated $247M increase.
- Jim Simons's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $227M.
- Jim Simons fully exited Alphabet (Google) Class C in Q4 2016, selling an estimated $205M.
- Jim Simons's ten largest holdings make up 7.2% of its $63.2B portfolio in Q4 2016.
- Jim Simons opened 418 new positions and closed 494 in Q4 2016.
- Jim Simons's portfolio value rose 12% quarter-over-quarter to $63.2B.
Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.